↓ Skip to main content

The Who, What, and Why of Drug Discovery and Development

Overview of attention for article published in Trends in Pharmacological Sciences, October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Who, What, and Why of Drug Discovery and Development
Published in
Trends in Pharmacological Sciences, October 2018
DOI 10.1016/j.tips.2018.08.002
Pubmed ID
Authors

Glenn Hogan, Mark Tangney

Abstract

Inquiry into declining pharmaceutical R&D efficiency has focussed on 'what' can be improved, with only brief thought given to 'who' can be improved. Here, we argue that enabling people in the idea-to-product chain to have a more holistic knowledge of the behaviours and incentives of each other can optimise R&D.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 13%
Student > Ph. D. Student 5 13%
Student > Master 5 13%
Student > Bachelor 4 10%
Researcher 4 10%
Other 8 21%
Unknown 8 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 23%
Medicine and Dentistry 4 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 10%
Business, Management and Accounting 3 8%
Chemistry 2 5%
Other 7 18%
Unknown 10 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2018.
All research outputs
#6,867,950
of 13,514,418 outputs
Outputs from Trends in Pharmacological Sciences
#1,450
of 1,817 outputs
Outputs of similar age
#107,696
of 265,591 outputs
Outputs of similar age from Trends in Pharmacological Sciences
#11
of 16 outputs
Altmetric has tracked 13,514,418 research outputs across all sources so far. This one is in the 48th percentile – i.e., 48% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,817 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,591 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.